Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study to Explore and Evaluate Individualized Targeted Agents for Patients of Digestive Cancers Based on Molecular Characteristics After Standard Therapy Failure in China

NCT04584008 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT04584008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04584008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study to Explore and Evaluate Individualized Targeted Agents for Patients of Digestive Cancers Based on Molecular Characteristics After Standard Therapy Failure in China
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 23, 2020
Completion date
March 31, 2025
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract neoplasms, colorectal cancer, digestive cancer, esophageal squamous cell carcinoma, gastric cancer, gastrointestinal stromal tumors, neuroendocrine tumors, pancreatic cancer, unknown primary cancer